CR Group L.P. - 10%+ Owner at T2 Biosystems, Inc.

Issuer-level insider activity

Role: 10%+ Owner
Issuer ticker: TTOO
Entity type: Company
Source filing history: Open source filing history

No buys or sells have been reported by CR Group L.P. since 12 Sep 2025

Reported holdings for CR Group L.P. in T2 Biosystems, Inc.

Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class: Common Stock
Shares / value: 4,704,729
Estimated value: $740,995
Report date: 09 May 2024
Price: $0.1575
Ownership: By CRG Partners III - Parallel Fund B (Cayman) L.P.

Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class: Series A Convertible Preferred Stock
Shares / value: 28,036
Estimated value
Report date: 12 Apr 2024
Price
Ownership: By CRG Partners III - Parallel Fund B (Cayman) L.P.
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class: Series A Preferred Stock
Shares / value: 0
Estimated value
Report date: 09 May 2024
Price
Ownership: By CRG Partners III - Parallel Fund B (Cayman) L.P.
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class: Series B Preferred Stock
Shares / value: 0
Estimated value
Report date: 09 May 2024
Price
Ownership: By CRG Partners III - Parallel Fund B (Cayman) L.P.
Underlying class: Common Stock
Underlying amount

Transaction history for CR Group L.P. in T2 Biosystems, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .